1. Home
  2. ADTN vs FTRE Comparison

ADTN vs FTRE Comparison

Compare ADTN & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADTN
  • FTRE
  • Stock Information
  • Founded
  • ADTN 1985
  • FTRE 1996
  • Country
  • ADTN United States
  • FTRE United States
  • Employees
  • ADTN N/A
  • FTRE N/A
  • Industry
  • ADTN Telecommunications Equipment
  • FTRE Medical Specialities
  • Sector
  • ADTN Telecommunications
  • FTRE Health Care
  • Exchange
  • ADTN Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • ADTN 616.5M
  • FTRE 469.0M
  • IPO Year
  • ADTN 1994
  • FTRE N/A
  • Fundamental
  • Price
  • ADTN $7.72
  • FTRE $6.16
  • Analyst Decision
  • ADTN Strong Buy
  • FTRE Hold
  • Analyst Count
  • ADTN 4
  • FTRE 11
  • Target Price
  • ADTN $12.50
  • FTRE $18.00
  • AVG Volume (30 Days)
  • ADTN 864.7K
  • FTRE 2.3M
  • Earning Date
  • ADTN 05-07-2025
  • FTRE 05-12-2025
  • Dividend Yield
  • ADTN N/A
  • FTRE N/A
  • EPS Growth
  • ADTN N/A
  • FTRE N/A
  • EPS
  • ADTN N/A
  • FTRE N/A
  • Revenue
  • ADTN $944,291,000.00
  • FTRE $2,696,400,000.00
  • Revenue This Year
  • ADTN $14.44
  • FTRE N/A
  • Revenue Next Year
  • ADTN $9.66
  • FTRE $3.32
  • P/E Ratio
  • ADTN N/A
  • FTRE N/A
  • Revenue Growth
  • ADTN N/A
  • FTRE N/A
  • 52 Week Low
  • ADTN $4.34
  • FTRE $4.77
  • 52 Week High
  • ADTN $12.44
  • FTRE $37.24
  • Technical
  • Relative Strength Index (RSI)
  • ADTN 45.09
  • FTRE 43.72
  • Support Level
  • ADTN $7.49
  • FTRE $5.40
  • Resistance Level
  • ADTN $8.26
  • FTRE $6.10
  • Average True Range (ATR)
  • ADTN 0.31
  • FTRE 0.43
  • MACD
  • ADTN 0.08
  • FTRE 0.20
  • Stochastic Oscillator
  • ADTN 48.00
  • FTRE 70.59

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: